NeuroRays specializes in the advanced delivery of select photo-biomodulation (“PBM”) light wavelengths to the retina of the human eye.  NeuroRays has invented, developed, and patented ocular PBM technology, that protects one, or all of, the fovea, parafovea, perifovea or all the macula while simultaneously stimulating the peripheral retina. The NeuroRays PBM technology provides a proprietary irradiance level and blend of multiple PBM light wavelengths to activate specific photoreceptors, as well as other cells, in the retina in order to noninvasively affect the physiology of the human eye. In certain targeted cases, the PBM light stimulus modulates neurotransmitter release via cellular photo-biomodulation pathways, thus positively impacting the health and wellbeing of the human eye.  In other targeted cases the PBM light stimulus modulates neurotransmitter release that can positively impact certain neurological disorders.